Biosafety Level 4 Laboratories: Design, Operational Protocols, and Diagnostic Applications

Biosafety Level 4 (BSL-4) laboratories are maximum containment facilities designed for work with dangerous pathogens that pose a high individual risk of life-threatening disease and for which no vaccines or treatments are available. These facilities combine engineering controls, strict operational protocols, and specialized training to protect laboratory workers, the community, and the environment from exposure to risk group 4 agents. For diagnostic professionals, understanding BSL-4 requirements is essential for recognizing when such facilities are needed, how they function, and what capabilities they provide for identifying high-consequence pathogens. This article explains the design principles, operational requirements, and diagnostic applications of BSL-4 laboratories, with attention to the practical decisions that laboratory managers, biosafety officers, and diagnostic staff must make.

The Biosafety Level Framework

The biosafety level system provides a graduated approach to containment based on the risk posed by biological agents. Each level builds on the previous one, adding engineering controls, management practices, and facility design features that increase protection. The World Health Organization's Laboratory Biosafety Manual describes the principles and practices for safe handling of infectious microorganisms across all biosafety levels. The framework helps laboratories match their containment measures to the specific hazards of the agents they handle.

Comparison of Biosafety Levels 1 through 4

The progression from BSL-1 to BSL-4 reflects increasing agent hazard and correspondingly more stringent containment requirements. Diagnostic laboratories typically operate at BSL-2 or BSL-3, but certain high-consequence pathogens require BSL-4 containment for culture and amplification work.

Agents Requiring BSL-4 Containment

Risk group 4 pathogens include viruses that cause severe hemorrhagic fevers and other life-threatening diseases. These agents share common characteristics: high morbidity and mortality in humans, potential for aerosol transmission, and absence of effective vaccines or therapeutic interventions. The Nipah virus is classified as a biosafety level 4 pathogen and is transmitted by fruit bats of the Pteropus genus, with human-to-human transmission also documented. Ebola virus and Marburg virus are also classified as BSL-4 pathogens and are Category A agents for which governments require preparedness against potential misuse.

The classification of an agent as BSL-4 has direct implications for diagnostic work. While some diagnostic procedures can be performed at lower containment levels using inactivated samples, any procedure that involves culturing the live virus or concentrating infectious material must occur within a BSL-4 facility. This creates a diagnostic pathway where initial screening may occur at lower containment, but confirmatory culture and characterization require maximum containment.

Facility Design and Engineering Controls

The physical design of a BSL-4 laboratory is the foundation of its containment function. These facilities are either constructed as separate buildings or as clearly demarcated zones within a larger building, with dedicated supply and exhaust air systems, controlled access, and complete decontamination of all liquid and solid waste.

Primary Containment Systems

BSL-4 laboratories use one of two primary containment approaches. The first approach uses Class III biological safety cabinets, which are gas-tight enclosures with glove ports that provide a complete physical barrier between the worker and the infectious material. The second approach uses positive pressure suits worn by laboratory workers, combined with Class II biological safety cabinets for manipulation of infectious materials. The positive pressure suit approach, also called the suit-type laboratory, is used in most current BSL-4 facilities.

Positive pressure protective suits serve as the primary barrier that protects and isolates laboratory workers from pathogens and the laboratory environment. A suit developed for the first Japanese suit-type BSL-4 laboratory at Nagasaki University was modified from a domestic chemical protective suit, with changes to the front face shield, cuff, and air supply hose for safe handling of microbiological agents. The improved suit demonstrated resistance to several chemicals including quaternary ammonium disinfectant and showed no permeation against blood and phages. An airtight test was established to validate suit integrity and eliminate individual differences in quantitative testing.

Airflow and Pressure Management

BSL-4 laboratories maintain negative air pressure relative to surrounding areas, ensuring that air flows into the laboratory instead of out of it. The ventilation system uses dedicated supply and exhaust pathways, with high-efficiency particulate air filtration on both intake and exhaust. Airflow organization directly affects aerosol infection risk within the laboratory, and optimization of airflow patterns is an active area of facility design research.

The pressure differentials between laboratory zones create a cascade effect, with the most hazardous areas at the lowest pressure. Entry through an airlock or chemical shower provides a transition zone where personnel can decontaminate suit surfaces before leaving the containment area. The exhaust air passes through two high-efficiency particulate air filters in series before release to the environment.

Effluent Decontamination

All liquid waste from a BSL-4 laboratory, including shower water, suit decontamination runoff, and liquid effluents from laboratory procedures, must be decontaminated before release. This is typically accomplished through heat treatment in a dedicated effluent decontamination system. Solid waste is decontaminated by double-door autoclaves that allow waste to be loaded from inside the containment area and removed from outside without breaking containment.

Energy and Environmental Considerations

BSL-4 laboratories are energy-intensive facilities due to the high air exchange rates, filtration requirements, and temperature control needed for both worker safety and sample integrity. Energy efficiency analysis and life cycle assessment of BSL-4 laboratories examine the environmental impact of these facilities over their operational lifetime. Facility managers must balance the rigorous engineering requirements of containment with operational sustainability, recognizing that energy consumption is a significant and ongoing operational cost.

Operational Protocols and Personnel Training

The safe operation of a BSL-4 laboratory depends on experienced and qualified personnel with appropriate skills and knowledge of biorisk management. Certification of these personnel is a prerequisite for ensuring safety of users involved in research in a BSL-4 laboratory. Training programs must follow national and international guidelines and regulations, and they often refer to experiences and materials derived from multiple BSL-4 facilities in other countries.

Training Program Components

A comprehensive BSL-4 training program covers multiple domains. New personnel must demonstrate competence in donning and doffing positive pressure suits, operating entry and exit procedures, handling infectious materials within the containment environment, responding to emergencies, and performing decontamination procedures. The training program developed for the Nagasaki University BSL-4 facility was designed to follow national and international guidelines and regulations, incorporating materials from multiple BSL-4 facilities in other countries. The established training program system, including the formulation processes, serves as a reference and provides practical materials for other research organizations to develop their own high-containment laboratory training programs.

Training is not a one-time event. Personnel must participate in regular refresher training, proficiency assessments, and emergency drills. The training program must also address the psychological demands of working in maximum containment, where errors can have fatal consequences and where the physical constraints of protective suits create additional stress.

Medical Surveillance

Personnel working in BSL-4 laboratories participate in medical surveillance programs that include baseline health assessment, periodic health monitoring, and documentation of any laboratory exposures. Some facilities implement routine screening for accidental laboratory-acquired infections as an additional layer of protection. Modeling studies suggest that routine testing of laboratory workers can significantly reduce the risk of outbreaks following an initial laboratory-acquired infection, with even relatively infrequent testing providing meaningful risk reduction under diverse plausible scenarios.

Entry and Exit Procedures

Entry into a BSL-4 laboratory follows a strict sequence. Personnel change into dedicated laboratory clothing, don the positive pressure suit, check suit integrity, and pass through an airlock. The airlock may include a chemical shower for suit decontamination on exit. Exit procedures require decontamination of the suit surface, removal of the suit in a designated area, and a personal shower before leaving the facility. Every entry and exit is logged, and access is limited to trained and approved personnel.

Diagnostic Applications of BSL-4 Laboratories

BSL-4 laboratories play a critical role in diagnosing infections caused by high-consequence pathogens. Their diagnostic functions include virus isolation, characterization of clinical specimens, validation of diagnostic assays, and support for outbreak response.

Virus Isolation and Culture

The definitive diagnosis of many BSL-4 pathogens requires isolation of the live virus from clinical specimens. This work must occur within maximum containment because culturing amplifies the virus to concentrations that pose an unacceptable risk outside BSL-4. Diagnostic specimens from patients with suspected viral hemorrhagic fever are processed in BSL-4 facilities to attempt virus isolation in cell culture systems.

Molecular Diagnostics

Molecular diagnostic methods, including polymerase chain reaction-based assays, can be performed on inactivated samples at lower containment levels. However, the development and validation of these assays often requires access to BSL-4 facilities for generating reference materials, testing assay sensitivity and specificity against live virus, and validating the inactivation procedures that allow safe downstream processing. Different types of enzyme-linked immunosorbent assays along with molecular methods based on polymerase chain reaction have been developed for diagnostic purposes for Nipah virus.

Surrogate and Recombinant Systems

The limited availability of BSL-4 laboratories can slow diagnostic assay development during epidemics. One approach to address this constraint is the use of synthetic constructs that serve as safe surrogates for BSL-4 pathogens. A synthetic Ebola virus construct in a bacterial surrogate remained stable and safe after several generations, serving as an effective positive control in research settings and point-of-care detection platforms. This approach allows assay development and validation to proceed at lower containment levels while maintaining diagnostic relevance.

Recombinant protein-based diagnostics for viral hemorrhagic fevers offer another pathway for developing detection methods that do not require live virus. These approaches use recombinant proteins as antigens for serological assays, enabling diagnostic development outside maximum containment.

Outbreak Response Support

BSL-4 laboratories provide essential support during outbreaks of high-consequence pathogens. During the Marburg virus disease outbreak in Ethiopia that began in November 2025, the response included laboratory confirmation, deployment of mobile high-biosafety laboratories, and establishment of isolation and treatment centers. More than 3,800 diagnostic tests were conducted during that outbreak, leading to identification of 19 cases. The outbreak response demonstrated the critical role of high-containment diagnostic capacity in confirming cases and guiding public health action.

Risk Assessment and Management

Risk assessment is the foundation of biosafety decision-making in BSL-4 laboratories. The process identifies hazards, evaluates the likelihood and consequences of exposure, and determines the appropriate containment measures. Risk assessment must be conducted before any new procedure is introduced and must be reviewed whenever conditions change.

Aerosol Risk

Aerosol generation is a primary exposure route in BSL-4 laboratories. Procedures that create aerosols, including pipetting, centrifugation, sonication, and tissue homogenization, require additional precautions beyond those used for standard manipulations. Assessment of aerosol infection risk and airflow organization optimization in BSL-4 laboratories examines how facility design can reduce the probability of aerosol exposure. The placement of supply and exhaust vents, the direction of airflow within the laboratory, and the location of workstations all influence aerosol dispersion patterns.

Sharps and Procedural Hazards

The use of sharp instruments poses particular risks in high containment. Needles, scalpels, and other sharps can puncture protective suits or gloves, creating a direct exposure pathway. Many BSL-4 laboratories minimize or eliminate sharps use through engineering controls and procedural modifications. When sharps are necessary, they are handled with extreme care and disposed of in puncture-resistant containers that are decontaminated before removal from the laboratory.

Disinfectant Validation

Effective disinfection is essential for maintaining biosafety in high-containment laboratories. Disinfectants used in BSL-4 facilities must be validated for efficacy against the specific pathogens being handled. Validation studies must account for the potential cytotoxicity of disinfectants in cell culture systems, which can lead to overestimation of virucidal efficacy. A study of Micro-Chem Plus, a disinfectant widely used in high-containment facilities, found that a 400-fold dilution with assay medium completely neutralized the disinfectant, but reliable detection required high viral titers. Chemical neutralization using Dey-Engley broth showed inherent cytotoxicity, while chromatographic separation was the most effective neutralization method but required an additional dilution step. Validation in a BSL-4 facility with Ebola virus confirmed the disinfectant's concentration- and time-dependent virucidal activity.

Records and Documentation

Comprehensive documentation is a cornerstone of BSL-4 laboratory operations. Records serve multiple functions: they demonstrate compliance with regulatory requirements, support training and competency assessment, enable investigation of incidents, and provide data for continuous improvement.

Required Records

BSL-4 facilities maintain records of personnel training and certification, medical surveillance results, equipment certification and maintenance, environmental monitoring, waste decontamination, and all entries and exits from the containment area. A computerized data-capture system for animal biosafety level 4 laboratories demonstrates how electronic systems can support documentation requirements in maximum containment environments. These systems track animal identification, experimental procedures, and health status while maintaining the integrity of the containment barrier.

Incident Reporting

Any breach of containment, exposure to infectious material, or equipment failure must be documented and investigated. Incident reports describe what happened, what actions were taken, and what changes are needed to prevent recurrence. The investigation process examines both immediate causes and contributing factors, including human performance, equipment function, and procedural design.

Quality Management

BSL-4 diagnostic laboratories operate within a quality management framework that ensures reliable test results. The World Health Organization's Laboratory Quality Management System Handbook describes the components of a quality management system for laboratories, including organization, personnel, equipment, purchasing and inventory, process control, information management, documents and records, occurrence management, assessment, process improvement, customer service, and facilities and safety. These components apply to BSL-4 diagnostic work, with additional requirements imposed by the containment environment.

Common Failure Patterns and Troubleshooting

Understanding how BSL-4 systems fail helps laboratory personnel identify problems early and respond effectively. Several failure patterns recur across facilities.

Suit Integrity Failures

Positive pressure suits can develop leaks or tears that compromise their protective function. Regular inspection and testing of suits is essential. The airtight test developed for the Nagasaki BSL-4 suit eliminated individual differences for quantitative testing, providing a reliable method for verifying suit integrity. Personnel should inspect suits before each use and report any damage immediately.

Airflow Disruptions

The negative pressure cascade that contains airborne pathogens depends on properly functioning ventilation systems. Failures in supply or exhaust fans, blocked filters, or improperly sealed doors can disrupt airflow patterns and compromise containment. Environmental monitoring systems that continuously measure pressure differentials provide early warning of airflow problems. When airflow disruptions occur, work with infectious materials must stop until the system is restored and verified.

Decontamination Failures

Autoclaves and effluent decontamination systems can fail to achieve the required temperature or exposure time, leaving waste inadequately treated. Routine biological indicators verify that decontamination cycles are effective. When a decontamination failure is detected, the affected waste is reprocessed, and the system is serviced before further use.

Human Error

Human error remains a significant risk factor in BSL-4 operations despite extensive training. Errors in procedure sequence, communication failures, and lapses in attention can all lead to containment breaches. The high-stress environment of maximum containment work increases the potential for error. Facilities address this through redundant checks, clear standard operating procedures, and a culture that encourages reporting of errors without fear of punishment.

Limitations and Constraints

BSL-4 laboratories face significant limitations that affect their diagnostic capabilities and operational sustainability.

Limited Global Capacity

The number of BSL-4 laboratories worldwide is small, and their geographic distribution is uneven. Many countries have no BSL-4 capacity at all. A study of microbiological laboratories in Ukraine found that only two laboratories were allowed to work with microorganisms of the first pathogenic group, and there were no BSL-4-compliant laboratories in the country. This limited capacity creates challenges for outbreak response, particularly in regions where high-consequence pathogens are endemic or emerging.

Operational Costs

The construction and operation of BSL-4 laboratories require substantial financial resources. The energy demands of maintaining negative pressure, filtering air, and treating effluents are significant and ongoing. Energy efficiency analysis and life cycle assessment of BSL-4 laboratories examine the environmental impact of these facilities over their operational lifetime, providing data that can inform decisions about facility design and operation.

Training Requirements

The specialized training required for BSL-4 work creates a bottleneck in workforce development. Training programs take considerable time to complete, and the pool of qualified personnel remains small. The development of training programs that can be shared across institutions helps address this constraint, as demonstrated by the training program established for the Nagasaki University facility, which was designed to serve as a reference for other research organizations.

Diagnostic Pathway Constraints

The requirement for BSL-4 containment for virus isolation creates delays in the diagnostic pathway. Samples must be transported to a BSL-4 facility, which may be in another country. The development of molecular diagnostic methods that can be performed on inactivated samples at lower containment levels helps address this constraint, but these methods must be validated against live virus, which requires BSL-4 access.

Safety and Regulatory Context

BSL-4 laboratories operate within a complex regulatory environment that includes national laws, international guidelines, and institutional policies. The World Health Organization's Laboratory Biosafety Manual provides international guidance on biosafety practices, while individual countries have their own regulations governing high-containment facilities.

International Guidelines

The WHO Laboratory Biosafety Manual describes the principles of biosafety and the requirements for each biosafety level. The Laboratory Quality Management System Handbook complements this guidance by addressing the quality management aspects of laboratory operations. Together, these documents provide a framework for BSL-4 laboratory operation that is applicable across national contexts.

National Oversight

Individual countries regulate BSL-4 facilities through their public health and agricultural agencies. These regulations typically address facility design and certification, personnel training and certification, agent possession and transfer, and incident reporting. The regulatory framework for BSL-3 laboratories in India, developed under the National One Health Mission, includes a standard assessment tool that evaluates staff training, sample handling and transportation, sample processing and testing procedures, data management and reporting, biomedical waste management, emergency preparedness and response, and general biosafety. Similar assessment approaches can be applied to BSL-4 facilities.

One Health Integration

The One Health approach recognizes the interconnections between human, animal, and environmental health. High-consequence pathogens often have zoonotic origins, and their detection requires collaboration across human and animal health sectors. The Research Alliance for Veterinary Science and Biodefense BSL-3 Network was established to improve collaboration between public health and veterinary infectious disease communities, with the objective of harnessing collective large-animal biocontainment infrastructure and research capacity to improve bio-surveillance, diagnostics, and countermeasure development against high-consequence pathogens of veterinary and zoonotic importance. Nipah virus preparedness within a One Health framework emphasizes integrated surveillance across human, animal, and environmental domains for early identification of spillover signals.

Professional Escalation Criteria

Laboratory personnel must know when to escalate concerns to supervisors, biosafety officers, or institutional leadership. Clear escalation criteria ensure that problems are addressed promptly and appropriately.

Immediate Escalation

Any suspected or confirmed exposure to infectious material requires immediate escalation. This includes needlesticks, cuts, splashes to mucous membranes, and breaches in suit integrity. The affected individual exits the laboratory following decontamination procedures and receives medical evaluation. The incident is reported to the biosafety officer and institutional leadership.

Urgent Escalation

Equipment failures that could compromise containment require urgent escalation. This includes ventilation system failures, autoclave malfunctions, and effluent decontamination system failures. Work with infectious materials stops until the system is restored and verified. The biosafety officer is notified, and the incident is documented.

Routine Escalation

Observations that suggest emerging problems should be escalated through normal reporting channels. This includes recurring equipment issues, patterns of near-misses, and observations that procedures are not being followed consistently. These reports contribute to continuous improvement efforts and help prevent more serious incidents.

Frequently Asked Questions

What is the difference between BSL-3 and BSL-4 laboratories?

BSL-3 laboratories handle agents that can cause serious or lethal disease but for which treatment is available. BSL-4 laboratories handle agents that cause life-threatening disease with no available treatment. BSL-4 adds positive pressure suits or Class III biological safety cabinets, complete effluent decontamination, and more stringent access control. The facility is typically a separate building or isolated zone with dedicated air handling systems.

Which pathogens require BSL-4 containment?

Risk group 4 pathogens include Ebola virus, Marburg virus, Nipah virus, and other agents that cause severe hemorrhagic fevers or encephalitis with high mortality and no effective treatment. These agents are classified as BSL-4 pathogens because they pose a high individual risk of life-threatening disease and have potential for aerosol transmission.

Can diagnostic testing for BSL-4 pathogens be done at lower containment levels?

Some diagnostic procedures can be performed at lower containment levels using inactivated samples. Molecular methods such as polymerase chain reaction can be applied to samples that have been chemically inactivated. However, virus isolation and culture require BSL-4 containment because these procedures amplify the live virus. Assay development and validation also require BSL-4 access for generating reference materials and testing against live virus.

How do positive pressure suits protect laboratory workers?

Positive pressure suits maintain higher air pressure inside the suit than in the surrounding laboratory. This pressure differential ensures that any leak in the suit results in air flowing outward instead of inward, preventing pathogen entry. The suit is supplied with filtered air through a hose, and the worker breathes this supplied air instead of laboratory air. Suit integrity is verified through airtight testing before use.

What training is required to work in a BSL-4 laboratory?

Personnel must complete a comprehensive training program covering suit use, entry and exit procedures, handling of infectious materials, emergency response, and decontamination. Training follows national and international guidelines and often incorporates materials from established BSL-4 facilities. Personnel must demonstrate competency through practical assessments and participate in regular refresher training.

How is waste decontaminated in a BSL-4 laboratory?

Solid waste is decontaminated in double-door autoclaves that allow loading from inside the containment area and removal from outside. Liquid waste, including shower water and suit decontamination runoff, is treated in an effluent decontamination system that uses heat to inactivate pathogens before release. All waste must be decontaminated before leaving the facility.

What happens if there is a containment breach in a BSL-4 laboratory?

A containment breach triggers immediate response procedures. The affected individual exits the laboratory following decontamination protocols and receives medical evaluation. Work with infectious materials stops, and the facility is secured. An investigation identifies the cause of the breach and determines what corrective actions are needed. The incident is documented and reported to institutional leadership and relevant authorities.

Why are there so few BSL-4 laboratories in the world?

BSL-4 laboratories require substantial financial investment for construction and operation. The engineering requirements are complex, including dedicated air handling systems, effluent decontamination, and specialized safety equipment. Personnel must complete extensive training, and the pool of qualified workers is small. The limited number of agents requiring BSL-4 containment and the geographic distribution of these agents also influence where facilities are built.

Related Diagnostic Guides

• Process Controls in Microbiology: Internal Amplification Controls and Their Role
• Process Controls in PCR: Internal Amplification Controls and Their Role in Validation
• Biosafety Cabinet Types and Selection Guide for Microbiology Laboratories
• Comparison of Southern, Northern, and Western Blotting: Principles and Applications
• Proper Laboratory Attire: Safety Requirements and Best Practices

References and Further Reading

• Laboratory Quality Management System Handbook. World Health Organization.
• Laboratory Biosafety Manual. World Health Organization.
• Assay Guidance Manual. National Center for Advancing Translational Sciences.
• Bioanalytical Method Validation Guidance. U.S. Food and Drug Administration.
• NCBI Literature Resources. National Center for Biotechnology Information.
• Design and Construction of a Biosafety Level 3 Autopsy Laboratory.. Archives of pathology & laboratory medicine, 2021.
• [Developing a Biosafety Level 4 Laboratory user training program].. Uirusu, 2022.
• Nipah virus: epidemiology, pathology, immunobiology and advances in diagnosis, vaccine designing and control strategies - a comprehensive review.. The veterinary quarterly, 2019.
• Compact Arterial Monitoring Device Use in Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA): A Simple Validation Study in Swine.. Cureus, 2024.
• Development of a Novel Positive Pressure Protective Suit for a Biosafety Level 4 Laboratory in Japan.. Japanese journal of infectious diseases, 2023.
• Functional cure with new antiviral therapy for hepatitis B virus: a systematic review and meta-analysis.. Hepatology international, 2025.
• Biological safety cabinetry.. Clinical microbiology reviews, 1991.
• Update of Arthropod Containment Guidelines.. Applied biosafety : journal of the American Biological Safety Association, 2019.
• Nipah virus preparedness in a One Health framework: Implications for Europe.. 2026.
• A framework for evaluating biosafety and biosecurity in national network of biosafety level-3 laboratories in India: an initiative under national one health mission.. 2025.
• Modeling the effects of routine screening for accidental lab-acquired infections on the risk of potential pandemic pathogen escape from high-biosafety research facilities.. 2026.
• Optimised Neutralisation Strategies for Validating the Virucidal Efficacy of Micro-Chem Plus™ Against High-Containment Negative-Sense RNA Viruses.. 2025.
• Emergence of Marburg virus disease in Ethiopia: Implications for public health preparedness and its impact on Ethiopia's health system.. 2026.
• One Health Approach in Ukraine: Current Status and Prospects for Implementation.. 2026.
• Research Alliance for Veterinary Science and Biodefense BSL-3 Network (RAV3N): Report on network origin and phase I activities. Antiviral Research, 2023.
• Peculiarities of carrying out pre-vaccination diagnostics in Ukraine in order to determine the organism adaptability. Futurity Medicine, 2023.
• Synthetic Biology Construct of Ebola Virus in Bacteria Surrogate Is Stable and Safe for Rapid Detection Studies in a BSL-2 Laboratory Setting. Advances in microbiology, 2022.
• Recombinant Protein-Based Diagnostics for Viral Hemorrhagic Fevers. 2018.
• Animal models for Ebola and Marburg virus infections. Frontiers in Microbiology, 2013.
• Energy efficiency analysis and life cycle assessment of a biosafety level 4 laboratory. Energy and Buildings, 2025.
• Assessment of aerosol infection risk and airflow organization optimization in biosafety level 4 laboratories. Journal of Building Engineering, 2025.
• Environmental risk and assessment management system of high-level biosafety laboratory. Procedia Environmental Sciences, 2011.
• Key issues and countermeasures for constructing high-level biosafety laboratories. Experimental Technology and Management, 2024.
• A computerized data-capture system for animal biosafety level 4 laboratories. Journal of the American Association for Laboratory Animal Science, 2011.

This article is educational and does not replace validated laboratory procedures, institutional biosafety review, manufacturer instructions, or professional interpretation.